X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (40) 40
humans (36) 36
immunotherapy (28) 28
article (27) 27
hematology (24) 24
immunology (23) 23
oncology (23) 23
transplantation (22) 22
female (21) 21
male (16) 16
adult (15) 15
cancer (15) 15
leukemia (15) 15
stem cells (15) 15
middle aged (14) 14
chronic myelogenous leukemia (13) 13
hemic and lymphatic diseases (13) 13
care and treatment (10) 10
leukemia, myeloid, acute - therapy (10) 10
stem-cell transplantation (10) 10
t-lymphocytes, cytotoxic - immunology (10) 10
acute myeloid-leukemia (9) 9
antigen (9) 9
cross-presentation (9) 9
fludarabine (9) 9
aml (8) 8
breast cancer (8) 8
hematology, oncology and palliative medicine (8) 8
hla-a2 antigen - immunology (8) 8
leukemia, myeloid, acute - immunology (8) 8
lymphocytes (8) 8
pr1 (8) 8
t cells (8) 8
treatment outcome (8) 8
versus-host-disease (8) 8
aged (7) 7
analysis (7) 7
health aspects (7) 7
immunity (7) 7
peptides - immunology (7) 7
acute myeloid leukemia (6) 6
animals (6) 6
antigens (6) 6
bone-marrow-transplantation (6) 6
breast neoplasms - immunology (6) 6
cell line, tumor (6) 6
cytotoxic t-lymphocytes (6) 6
immune response (6) 6
mice (6) 6
myeloblastin - immunology (6) 6
neutrophil elastase (6) 6
prognosis (6) 6
survival analysis (6) 6
transplantation, homologous (6) 6
abridged index medicus (5) 5
adaptive immunity (5) 5
allogeneic stem cell transplantation (5) 5
antigens, neoplasm - immunology (5) 5
cell biology (5) 5
clinical trials (5) 5
colony-stimulating factor (5) 5
expression (5) 5
hematopoietic stem cell transplantation (5) 5
histocompatibility antigens (5) 5
hla histocompatibility antigens (5) 5
leukemia, myeloid, acute - pathology (5) 5
lymphocytes t (5) 5
medical research (5) 5
myeloid leukemia (5) 5
therapy (5) 5
vaccination (5) 5
young adult (5) 5
antigen presentation (4) 4
busulfan (4) 4
cancer vaccines - therapeutic use (4) 4
chemotherapy (4) 4
chimerism (4) 4
conditioning regimen (4) 4
dendritic cells (4) 4
development and progression (4) 4
elastase (4) 4
epitopes - immunology (4) 4
epitopes, t-lymphocyte - immunology (4) 4
graft vs host disease - etiology (4) 4
graft vs host disease - prevention & control (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
hematopoietic stem cell transplantation - methods (4) 4
hematopoietic stem cells (4) 4
histocompatibility antigen hla (4) 4
leukemia, myeloid, acute - mortality (4) 4
leukocyte elastase - immunology (4) 4
leukocyte elastase - metabolism (4) 4
mds (4) 4
medicine, research & experimental (4) 4
myelodysplastic syndrome (4) 4
myelodysplastic syndromes - therapy (4) 4
patients (4) 4
peptide fragments - immunology (4) 4
peptides (4) 4
proteinase-3 (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


OncoImmunology, ISSN 2162-4011, 04/2013, Volume 2, Issue 4, pp. e23442 - e23442
Cathepsin G (CG) is a serine protease normally found within the azurophil granules of neutrophils. CG is expressed during the early stages of normal myeloid... 
AML | protease | leukemia | granule | myeloid | immunotherapy | cathepsin G | antigen | azurophil | target | Antigen | Target | Azurophil | Protease | Immunotherapy | Leukemia | Cathepsin G | Granule | Myeloid | ONCOLOGY | IMMUNOLOGY | Author's View
Journal Article
Cancer Research, ISSN 0008-5472, 10/2017, Volume 77, Issue 19, pp. 5374 - 5383
Early-phase clinical trials evaluating CD8(+) T cell-eliciting, HER2-derived peptide vaccines administered to HER2(+) breast cancer patients in the adjuvant... 
RESPONSES IN-VIVO | IMMUNE-COMPLEXES | FC-GAMMA RECEPTORS | ONCOLOGY | BREAST-CANCER PATIENTS | ANTIGEN PRESENTATION | MONOCLONAL-ANTIBODIES | EXPRESSION | CD8(+) T-CELLS | TUMOR-IMMUNITY | TRANSGENIC MICE | T-Lymphocytes, Cytotoxic - immunology | Cell Proliferation | Trastuzumab - therapeutic use | Breast Neoplasms - immunology | Dendritic Cells - immunology | Humans | Receptor, ErbB-2 - metabolism | Mice, Transgenic | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Animals | Female | Mice | Mice, Inbred BALB C | Ovarian Neoplasms - metabolism | Receptor, ErbB-2 - immunology | Tumor Cells, Cultured | CD8-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - drug therapy | Apoptosis | Ovarian Neoplasms - immunology | Flow cytometry | Therapy | Animal models | CD8 antigen | Vaccination | Medical services | Clinical trials | Cytotoxicity | Lymphocytes T | Vaccines | Immunity | Cell activation | Lymphocytes | Medical research | Antigen presentation | Immune response | Dendritic cells | Granulocyte-macrophage colony-stimulating factor | Breast cancer | T cell receptors | Adaptive immunity | Patients | ErbB-2 protein | Immune systems | Fc receptors | Cytometry | Monoclonal antibodies | Antitumor activity | Trastuzumab | Cancer | Index Medicus | trastuzumab | breast cancer | dendritic cells | cross-presentation | HER2
Journal Article
Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, ISSN 1078-0432, 05/2018, Volume 24, Issue 10, pp. 2304 - 2311
Purpose: We evaluated the effect on long-term survival of adding rituximab (R) to BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning with or... 
Transplants & implants | Clinical trials | Stem cell transplantation | Transplantation | Cytarabine | Melphalan | Remission | Conditioning | Medical research | Autografts | Cell survival | Etoposide | Rituximab | Patients | Survival | Lymphoma | Yttrium isotopes | Chemotherapy | Lymphocytes B | Experimental design | Stem cells | Lymphomas | Yttrium | Cancer | B-cell lymphoma
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 6/2016, Volume 65, Issue 6, pp. 741 - 751
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 7, pp. e11770 - e11770
Background: Interferon-alpha (IFN) induces complete cytogenetic remission (CCR) in 20-25% CML patients and in a small minority of patients; CCR persists after... 
CD34(+) CELLS | IN-VITRO | STEM-CELLS | DENDRITIC CELLS | ALPHA THERAPY | BIOLOGY | ABL GENOMIC REARRANGEMENT | SERINE-PROTEASE | IMATINIB MESYLATE | CHRONIC MYELOID-LEUKEMIA | LYMPHOCYTES | T-Lymphocytes, Cytotoxic - immunology | Peptides - chemistry | Humans | Middle Aged | Peptides - immunology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Interferon-gamma - metabolism | Remission Induction | Interferon-alpha - administration & dosage | Interferon-alpha - urine | Flow Cytometry | Peptides - chemical synthesis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Adult | Female | Cytogenetic Analysis | HLA-A2 Antigen - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology | Histocompatibility antigens | Peptides | Immunotherapy | HLA histocompatibility antigens | Interferon | B cells | Biological response modifiers | T cells | CD57 antigen | Cell proliferation | CC chemokine receptors | Transplants & implants | Anergy | Leukemia | CD45RA antigen | Proteinase | Cytotoxicity | Lymphocytes T | Kinases | CD28 antigen | Cancer therapies | Immunity | Cell growth | Immunology | Lymphocytes | Peripheral blood | Remission | Elastase | Protein-tyrosine kinase | Tyrosine | Antigens | Immunological memory | Memory cells | Imatinib | Cytokines | Dendritic cells | Myeloid leukemia | CCR7 protein | T cell receptors | Chronic myeloid leukemia | Patients | Studies | γ-Interferon | Stem cells | Histocompatibility antigen HLA | Proteinase 3 | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 05/2015, Volume 75, Issue 9 Supplement, pp. P5 - P5-04-07
Journal Article
Frontiers in immunology, ISSN 1664-3224, 2018, Volume 9, pp. 3153 - 3153
Despite substantial advances in the treatment of acute myeloid leukemia (AML), only 30% of patients survive more than 5 years. Therefore, new therapeutics are... 
re-directed cytotoxicity | bi-specific antibody | acute myeloid leukemia | PR1 | cancer immunotherapy | IMMUNITY | THERAPY | ACUTE MYELOID-LEUKEMIA | IMMUNOLOGY | CROSS-PRESENTATION | T cells | Research
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 4, pp. 4280 - 4281
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2012, Volume 18, Issue 12, pp. 1835 - 1844
Journal Article
OncoImmunology, ISSN 2162-4011, 04/2014, Volume 3, Issue 4, pp. e28325 - e28325
Early clinical trials investigating monoclonal antibodies targeting the T-cell inhibitory receptor programmed cell death 1 (PD-1) and its ligand PD-L1 have... 
PD-L1 | triple negative breast cancer | PI3K | biomarker | immunotherapy | Biomarker | Immunotherapy | Triple negative breast cancer | ONCOLOGY | SAFETY | ANTIBODY | IMMUNOLOGY
Journal Article
Journal of Immunology, ISSN 0022-1767, 09/2018, Volume 201, Issue 5, pp. 1389 - 1399
Proteinase 3 (P3), a serine protease expressed by myeloid cells, localized within azurophil granules, and also expressed on the cellular membrane of... 
WEGENERS-GRANULOMATOSIS | NEUTROPHIL PROTEINASE-3 | PROTEASE-ACTIVATED RECEPTOR-2 | SERINE PROTEASES | PROGNOSTIC-FACTORS | IMMUNE-RESPONSES | CATHEPSIN-G | IMMUNOLOGY | CATALYTIC-ACTIVITY | CANCER | CROSS-PRESENTATION | Index Medicus | Abridged Index Medicus | Immune Regulation
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 3243 - 3243
Introduction: 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 534 - 534
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.